Cobra Resources — Blue Rose drilling strengthens porphyry case

Cobra’s latest diamond drilling results strengthen the case for a larger copper-gold system beneath the shallow discovery at Blue Rose, within the Manna Hill Copper Project in South Australia.

Kooth — Improved profitability and growth drivers

Kooth’s H126 results show encouraging profitability improvements. Gross profit margins grew to 74% (H125: 63%), adjusted EBITDA more than doubled to £5.3m (H125: £2.6m) and profit after tax was £2m...

Altron — Continuing HEPS up 11–17% in H127

Altron has provided EPS ranges for its H127 results. Group headline EPS (HEPS) is expected to be 21–27% higher y-o-y at 105–110 ZAR cents and HEPS from continuing operations is expected to be 11–17%...

Newron Pharmaceuticals — H126 results: Evenamide pivotal readout nears

Newron Pharmaceuticals has reported its H126 results as lead asset evenamide approaches its first pivotal Phase III readout in treatment-resistant schizophrenia (TRS).

IP Group — Cash realisations reinforce portfolio momentum

IP Group’s results for the first half of 2026 (H126) provided further evidence of improving cash conversion and portfolio maturity.

Metlen Energy & Metals — 2026 shaping up well

PCI-PAL — Partnership with BT confirmed

PCI Pal has confirmed that the major telecom reseller signed up earlier this year is BT.

Boku — FY26 outlook maintained; strategic progress made

Boku reported H126 results broadly in line with July trading update, when the company noted several factors that had suppressed volume growth.

Georgia Capital — Building on its balance sheet strength

Georgia Capital (GCAP) enters its next phase from a considerably stronger financial position, supported by continued growth across its core holdings.

Invesco Asia Dragon Trust — Seamless management changes

Invesco Asia Dragon Trust’s (IAD’s) team evolution will be managed, with no changes to the long-term winning strategy.

Alter Ego Media — Strategy driving growth and higher profitability

The key takeaway from Alter Ego Media’s H126 results is the transformation strategy is showing through clearly in the figures.

Leading Edge Materials — Financing supports next phase at Norra Kärr

Leading Edge Materials (LEM) has raised C$4.3m of its targeted C$6.0m private placement, with cornerstone shareholder Eric Krafft committed to subscribe for any remaining units.

The Metals Company — Narrowing the NPV gap

The Metals Company (TMC) has continued to achieve regulatory milestones and, despite an interim shift in phasing, management continues to expect a commercial recovery permit before system commissio...

International Public Partnerships — Increased NAV and enhanced growth potential

International Public Partnerships’ (INPP’s) interim results (H126) show another period of strong operational and financial performance.

Noctiluca — Key qualification and funding milestones achieved

Noctiluca’s pathway towards industrial production has achieved two important milestones.

Baillie Gifford US Growth Trust — Board urges shareholders to reject Saba nominees

The board of Baillie Gifford US Growth Trust (USA) has responded to Saba Capital Management following receipt of a requisition notice on 24 August 2026, regarding the proposal to elect three people...

BioVersys — Clinical progress, commercial optionality

BioVersys’s H126 results mark a key transition in the investment case towards pivotal clinical execution.

MP Evans Group — Own crop and mill efficiency lift margins

MP Evans grows, mills and sells Indonesian crude palm oil (CPO) and palm kernels (PK).

Mendus — DIVA starts; testing combination with Ven+Aza

Mendus has initiated the Phase Ib DIVA trial, marking the first clinical evaluation of vididencel in combination with venetoclax and azacitidine (Ven+Aza)

Filtronic — Further US satellite progress

Filtronic has confirmed that it has won a follow-on contract from the unnamed US-based satellite customer that it started working with in March.